Teaching clinical pharmacology: coordination with medical pharmacology courses

Journal of Clinical Pharmacology
C M Lathers, C M Smith

Abstract

No abstract listed.

References

Jan 1, 1989·Journal of Clinical Pharmacology·A J IngenitoH J Burford
Feb 1, 1989·Journal of Clinical Psychopharmacology·A A Nierenberg, P E Keck
Oct 1, 1985·Pharmacology, Biochemistry, and Behavior·D M WoodM W Emmett-Oglesby
Apr 1, 1988·Journal of Medical Education·D P Hanes, R J Tallarida
Mar 1, 1988·Journal of Clinical Pharmacology·R J TallaridaL S Jacob
May 1, 1987·British Journal of Clinical Pharmacology·D J Sumner, H L Elliott
Jul 1, 1987·Reviews in Clinical & Basic Pharmacology·R Pohorecki, E F Domino
Jan 1, 1988·Annals of Internal Medicine·D C Brater, D W Nierenberg
Aug 1, 1988·Clinical Pharmacology and Therapeutics·R W Lievertz
Oct 1, 1987·Journal of Medical Education·D E McMillan, G R Wenger
Sep 1, 1987·Journal of Clinical Pharmacology·R D FeldmanR Roberts
Nov 1, 1986·Clinical Pharmacology and Therapeutics·D W Nierenberg
Nov 1, 1986·Clinical Pharmacology and Therapeutics·D W Nierenberg, T A Stukel
Apr 1, 1987·Clinical Pharmacology and Therapeutics·R I Ogilvie
Oct 1, 1985·Journal of Pharmacokinetics and Biopharmaceutics·L Z Benet
Mar 15, 1985·The American Journal of Cardiology·L Z Benet
Jul 1, 1985·Clinical Pharmacology and Therapeutics·M M Reidenberg
Feb 1, 1974·Journal of Clinical Pharmacology·W S Frankl, J Roberts
Jan 1, 1970·World Health Organization Technical Report Series
Mar 1, 1968·The Journal of Clinical Pharmacology and the Journal of New Drugs·H Gold
Apr 3, 1969·The New England Journal of Medicine·J C Fratantoni
Jul 1, 1969·Clinical Pharmacology and Therapeutics·K L Melmon, H F Morrelli
Jun 16, 1983·The New England Journal of Medicine·K L Melmon, T F Blaschke
May 1, 1984·Drug Intelligence & Clinical Pharmacy·J Wartak, D Fenna
Nov 1, 1983·Journal of Clinical Pharmacology·R Spector, R J Roberts
Jan 1, 1981·European Journal of Clinical Pharmacology·X Lataste, I J Whitehouse
Mar 1, 1980·Journal of Medical Education·J W FisherR Palmer
May 16, 1980·JAMA : the Journal of the American Medical Association·R I Wang
May 16, 1980·JAMA : the Journal of the American Medical Association·J R DiPalma

❮ Previous
Next ❯

Citations

Jul 1, 1991·Journal of Clinical Pharmacology·I L PinaE L Michelson
Aug 1, 1991·Journal of Clinical Pharmacology·D Robertson
Mar 1, 1991·Journal of Clinical Pharmacology·D E Hutcheon, H W el-Gawly
Feb 1, 1995·Journal of Clinical Pharmacology·A J Ingenito, W R Wooles
Jun 14, 2002·Academic Medicine : Journal of the Association of American Medical Colleges·Rodolfo RodriguezFermin Valenzuela
Jan 5, 2002·Journal of Clinical Pharmacology·P B WilliamsR L Volle
Jun 1, 1992·Journal of Clinical Pharmacology·A J IngenitoW R Wooles

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.